Maze Therapeutics, Inc. (MAZE)

NASDAQ

$29.63

$--

(0.00%)

Pre-Market

Maze Therapeutics, Inc. (MAZE) Live Price Chart

Last updated: ⁦2026-10-20 10:46:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Maze Therapeutics, Inc. (MAZE) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $29.63, with a market capitalization of $1.53B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $21.95 to $53.65. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.53B
Open	$29.63
Day's High	$53.65
Day's Low	$6.71
Previous Close	$29.70
Volume	41.00
Average Volume	612.66K
P/E Ratio	--
52-Week High	$53.65
52-Week Low	$21.95
Dividend Yield	--
Earnings Date	--

Maze Therapeutics, Inc. (MAZE) Pre-Market Stock Price

Maze Therapeutics, Inc. (MAZE) is trading at $29.63 in pre-market trading as of 2026-10-20 08:30:00, down 0.25% ($0.07) from the previous close of $29.70

Pre-market trading shows how investors are pricing MAZE before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Maze Therapeutics, Inc. (MAZE) 7-Day Stock Price Change

Over the past seven days, Maze Therapeutics, Inc. (MAZE) moved from $27.11 to $29.63, representing a gain of 9.28% ($2.52).

The stock traded between $25.88 and $30.57 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 916.35 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

MAZE 52-Week Price Position

Position in Range: 24.2%

52W Low$21.95

52W High$53.65

MAZE is currently trading at $29.63, placing it 24.2% of the way from its 52-week low of $21.95 to its 52-week high of $53.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Maze Therapeutics, Inc. (MAZE)?

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

Maze Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	141
Exchange	NASDAQ
Company Website	https://www.mazetx.com

How to Buy Maze Therapeutics, Inc. (MAZE) Stock on MEXC

Eligible investors can buy real shares of Maze Therapeutics, Inc. (MAZE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MAZE and Place Your Order

Open the RealStocks trading page and search for MAZE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Maze Therapeutics, Inc. (MAZE) stock price today?

Maze Therapeutics, Inc. (MAZE) is currently trading at $ 29.63, down 0.25% ($0.07) from the previous close of $ 29.70. Intraday prices update in real time during regular trading hours.

2.Is MAZE stock going up or down today?

As of 2026-10-20 08:30:00, MAZE is trading at $ 29.63, down 0.25% ($0.07) from its previous close of $ 29.70. The stock has traded between $ 6.71 and $ 53.65 during today’s regular session. Past price movements do not guarantee future results.

3.What is MAZE pre-market price?

As of 2026-10-20 08:30:00, MAZE is trading at $ 29.63 in pre-market trading, down 0.25% ($0.07) from the previous close of $ 29.70. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MAZE after-hours price?

As of 2026-10-20 08:30:00, MAZE is trading at $ 29.63 in after-hours trading, down 0.25% ($0.07) from the regular-session close of $ 29.70. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MAZE stock trading now?

MAZE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MAZE sit relative to its 52-week high and low?

Over the past 52 weeks, MAZE has traded between a low of $ 21.95 and a high of $ 53.65. At $ 29.63, the stock is positioned 24.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Maze Therapeutics, Inc. in?

Maze Therapeutics, Inc. (MAZE) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Maze Therapeutics, Inc.'s market capitalization and where is it listed?

Maze Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.53B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MAZE valued in terms of P/E ratio and EPS?

MAZE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.40. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Maze Therapeutics, Inc. pay a dividend?

Maze Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.